215 related articles for article (PubMed ID: 33920992)
1. Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD).
Mosiołek A; Pięta A; Jakima S; Zborowska N; Mosiołek J; Szulc A
J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33920992
[TBL] [Abstract][Full Text] [Related]
2. Effect of antidepressant treatment on peripheral inflammation markers - A meta-analysis.
Więdłocha M; Marcinowicz P; Krupa R; Janoska-Jaździk M; Janus M; Dębowska W; Mosiołek A; Waszkiewicz N; Szulc A
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):217-226. PubMed ID: 28445690
[TBL] [Abstract][Full Text] [Related]
3. The role of selective serotonin reuptake inhibitors in preventing relapse of major depressive disorder.
Clevenger SS; Malhotra D; Dang J; Vanle B; IsHak WW
Ther Adv Psychopharmacol; 2018 Jan; 8(1):49-58. PubMed ID: 29344343
[TBL] [Abstract][Full Text] [Related]
4. Application of antidepressants in depression: A systematic review and meta-analysis.
Yuan Z; Chen Z; Xue M; Zhang J; Leng L
J Clin Neurosci; 2020 Oct; 80():169-181. PubMed ID: 33099342
[TBL] [Abstract][Full Text] [Related]
5. The immunoregulatory effects of antidepressants.
Maes M
Hum Psychopharmacol; 2001 Jan; 16(1):95-103. PubMed ID: 12404604
[TBL] [Abstract][Full Text] [Related]
6. Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis.
Liu JJ; Wei YB; Strawbridge R; Bao Y; Chang S; Shi L; Que J; Gadad BS; Trivedi MH; Kelsoe JR; Lu L
Mol Psychiatry; 2020 Feb; 25(2):339-350. PubMed ID: 31427752
[TBL] [Abstract][Full Text] [Related]
7. Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis.
Lu S; Peng H; Wang L; Vasish S; Zhang Y; Gao W; Wu W; Liao M; Wang M; Tang H; Li W; Li W; Li Z; Zhou J; Zhang Z; Li L
Compr Psychiatry; 2013 Oct; 54(7):953-61. PubMed ID: 23639406
[TBL] [Abstract][Full Text] [Related]
8. Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis.
Köhler CA; Freitas TH; Stubbs B; Maes M; Solmi M; Veronese N; de Andrade NQ; Morris G; Fernandes BS; Brunoni AR; Herrmann N; Raison CL; Miller BJ; Lanctôt KL; Carvalho AF
Mol Neurobiol; 2018 May; 55(5):4195-4206. PubMed ID: 28612257
[TBL] [Abstract][Full Text] [Related]
9. Baseline Serum Levels of Beclin-1, but Not Inflammatory Factors, May Predict Antidepressant Treatment Response in Chinese Han Patients With MDD: A Preliminary Study.
He S; Zeng D; Xu F; Zhang J; Zhao N; Wang Q; Shi J; Lin Z; Yu W; Li H
Front Psychiatry; 2019; 10():378. PubMed ID: 31244689
[TBL] [Abstract][Full Text] [Related]
10. Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration.
Ohgi Y; Futamura T; Kikuchi T; Hashimoto K
Pharmacol Biochem Behav; 2013 Feb; 103(4):853-9. PubMed ID: 23262300
[TBL] [Abstract][Full Text] [Related]
11. Getting the balance right: Established and emerging therapies for major depressive disorders.
Perović B; Jovanović M; Miljković B; Vezmar S
Neuropsychiatr Dis Treat; 2010 Sep; 6():343-64. PubMed ID: 20856599
[TBL] [Abstract][Full Text] [Related]
12. Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD).
Mosiołek A; Mosiołek J; Jakima S; Pięta A; Szulc A
J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34362162
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of noradrenaline during the stress-induced major depressive disorder.
Seki K; Yoshida S; Jaiswal MK
Neural Regen Res; 2018 Jul; 13(7):1159-1169. PubMed ID: 30028316
[TBL] [Abstract][Full Text] [Related]
14. Monoamine neurocircuitry in depression and strategies for new treatments.
Hamon M; Blier P
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
[TBL] [Abstract][Full Text] [Related]
15. Are Noradrenergic Transmission Reducing Drugs Antidepressants?
Fitzgerald PJ
Front Behav Neurosci; 2021; 15():673634. PubMed ID: 34658805
[TBL] [Abstract][Full Text] [Related]
16. Severe depression: is there a best approach?
Sonawalla SB; Fava M
CNS Drugs; 2001; 15(10):765-76. PubMed ID: 11602003
[TBL] [Abstract][Full Text] [Related]
17. Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data.
Solem CT; Shelbaya A; Wan Y; Deshpande CG; Alvir J; Pappadopulos E
Neuropsychiatr Dis Treat; 2016; 12():2755-2764. PubMed ID: 27822048
[TBL] [Abstract][Full Text] [Related]
18. Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation.
Jha MK; Trivedi MH
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29329256
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
